(FNCL) Fidelity MSCI Financials - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3160925018 • Financial
FNCL: Banks, Insurance, Investment, Brokerages, Real Estate
The Fidelity MSCI Financials Index ETF, traded on the NYSE ARCA under the ticker FNCL, is designed to track the performance of the financial sector within the U.S. equity market. To achieve this, the fund invests a minimum of 80% of its assets in securities that are components of its underlying index, the MSCI USA IMI Financials 25/50 Index. This index is a broad representation of the financial sector, encompassing a wide range of financial companies, including banks, insurance companies, and financial services firms. By tracking this index, the ETF aims to provide investors with exposure to the overall financial sector in the U.S., allowing them to tap into the growth and income potential of this critical segment of the economy.
The MSCI USA IMI Financials 25/50 Index is a market-capitalization-weighted index, meaning that the securities within the index are weighted according to their market capitalization, with larger companies having a greater influence on the index's performance. This approach helps to ensure that the index, and by extension the ETF, is representative of the financial sector as a whole. It's worth noting that while the fund may hold a significant portion of the securities included in the MSCI USA IMI Financials 25/50 Index, it is not required to hold all of them, providing the fund managers with some flexibility in their investment decisions. Additionally, as a non-diversified fund, it can invest a larger percentage of its assets in a smaller number of securities, which may increase its potential for gain, but also its risk.
From a structural standpoint, the Fidelity MSCI Financials Index ETF is an exchange-traded fund (ETF) listed in the United States, with the ISIN US3160925018. It falls under the category of financial ETFs, which are designed to provide investors with targeted exposure to the financial sector. The fund's domicile in the United States and its listing on a major exchange like NYSE ARCA make it accessible to a wide range of investors, from individual investors to institutional clients. For more detailed information about the fund, including its investment objectives, strategies, and risks, investors can visit the company's website at http://www.institutional.fidelity.com.
Additional Sources for FNCL ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FNCL ETF Overview
Market Cap in USD | 2,089m |
Category | Financial |
TER | 0.08% |
IPO / Inception | 2013-10-21 |
FNCL ETF Ratings
Growth 5y | 68.9% |
Fundamental | - |
Dividend | 45.6% |
Rel. Strength Industry | 3.05 |
Analysts | - |
Fair Price Momentum | 74.69 USD |
Fair Price DCF | - |
FNCL Dividends
Dividend Yield 12m | 1.45% |
Yield on Cost 5y | 2.69% |
Annual Growth 5y | 1.84% |
Payout Consistency | 98.6% |
FNCL Growth Ratios
Growth Correlation 3m | 25.9% |
Growth Correlation 12m | 95% |
Growth Correlation 5y | 73.3% |
CAGR 5y | 13.11% |
CAGR/Mean DD 5y | 1.21 |
Sharpe Ratio 12m | 1.77 |
Alpha | 7.12 |
Beta | 1.08 |
Volatility | 20.30% |
Current Volume | 161.6k |
Average Volume 20d | 170.5k |
As of January 23, 2025, the stock is trading at USD 71.89 with a total of 161,600 shares traded.
Over the past week, the price has changed by +2.19%, over one month by +4.26%, over three months by +8.29% and over the past year by +35.40%.
Yes. Based on ValueRay Analyses, Fidelity MSCI Financials (NYSE ARCA:FNCL) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.86 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FNCL as of January 2025 is 74.69. This means that FNCL is currently overvalued and has a potential downside of 3.89%.
Fidelity MSCI Financials has no consensus analysts rating.
According to ValueRays Forecast Model, FNCL Fidelity MSCI Financials will be worth about 83.3 in January 2026. The stock is currently trading at 71.89. This means that the stock has a potential upside of +15.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 83.3 | 15.8% |